Cardiac resynchronization therapy in New York Heart Association class ‐IV patients dependent on intravenous drugs or invasive supportive treatments
ConclusionsCardiac resynchronization therapy implantation may be a feasible treatment that can offer short ‐term and long‐term clinical benefits for NYHA class‐IV FA‐HF patients who are dependent on IVDs/ISTs. When considering treatment options, CRT should not be prematurely excluded solely based on a patient's dependency on IVDs/ISTs without first attempting to identify favourable CRT response f actors.
Source: ESC Heart Failure - Category: Cardiology Authors: Seong Soo Lee,
Hee ‐Jin Kwon,
Kyoung‐Min Park,
Young Keun On,
June Soo Kim,
Seung‐Jung Park Tags: Original Research Article Source Type: research
More News: Cardiac Resynchronization Therapy | Cardiology | Heart | Heart Failure | Heart Transplant | Transplants